INTRODUCTION
In mammals, the methylation at 5mC occurs mainly at CpG dinucleotides and is required for fundamental physiological processes, such as embryonic development, X chromosome inactivation, and genomic imprinting (Okano et al., 1999; Pontier and Gribnau, 2011; Li, 2002) . Genome-wide analyses and functional studies allowed researchers to correlate DNA methylation with epigenetic modifications and to identify DNA elements that are necessary for DNA methylation Hawkins et al., 2010; Lienert et al., 2011) . However, the regulation of DNA methylation in stem cells and during early differentiation remains elusive.
DNA methylation is mediated by DNA methyltransferases (Dnmt), which include the maintenance enzyme Dnmt1 and the de novo Dnmt3. The family of the Dnmt3 includes two catalytically active members, Dnmt3a and Dnmt3b, and a catalytically inactive member called Dnmt3-like (Dnmt3L) (Bestor, 2000) (Jurkowska et al., 2011b) .
A crystallography study showed that Dnmt3L forms a heterotetrameric complex with Dnmt3a . It has been suggested that this tetramerization prevents Dnmt3a oligomerization and localization in heterochromatin (Jurkowska et al., 2011a) . In vitro experiments showed that Dnmt3L interacts with Dnmt3a or Dnmt3b and stimulates their activity (Ché din et al., 2002) (Chen et al., 2005; Gowher et al., 2005; Kareta et al., 2006) .
In mouse embryonic stem cells (ESCs), a large number of promoters are hypomethylated. DNA methylation increases during implantation to remain stable in fully differentiated cells (Borgel et al., 2010) . This methylation pattern does not correlate with Dnmt3L, which is highly expressed in ESCs, and its level drops with ESC differentiation to be re-expressed only in growing oocytes and in testes during a brief perinatal period (Bourc'his et al., 2001) (Bourc'his and Bestor, 2004) . In germ cells, Dnmt3L collaborates with Dnmt3a for the methylation of imprinted loci and retrotransposons (Hata et al., 2002; Kaneda et al., 2004) (Bourc'his et al., 2001; Bourc'his and Bestor, 2004) . Less clear is the role of Dnmt3L in ESCs, where Dnmt3L is highly expressed.
In ESCs, the Polycomb complex mediates the transcription repression of the genes involved in development, which is different from DNA methylation. Polycomb-mediated repression is considered to be less permanent because it maintains the possibility of activating the genes upon differentiation. It has been observed that H3K27me3-positive promoters are frequently DNA methylated during differentiation (Mohn et al., 2008) and are hypermethylated in cancer (Ohm et al., 2007; Schlesinger et al., 2007; Widschwendter et al., 2007; Simmer et al., 2012) , thus showing that H3K27me3 premarks genes for DNA methylation. A direct interaction between EZH2 of the Polycombrepressive complex 2 (PRC2) and the DNA methyltransferases Dnmt3a and Dnmt3b has been demonstrated (Rush et al., 2009; Viré et al., 2006) . However, a direct effect of this interaction and DNA methylation remains controversial because the binding of PRC2 is inhibited by DNA methylation in vitro (Bartke et al., 2010) , and genome-wide analysis reported mutual exclusiveness of H3K27me3 with DNA methylation in CpG islands (Lindroth et al., 2008; Wu et al., 2010; Brinkman et al., 2012) .
To study the role of Dnmt3L in mouse ESCs, we knocked down its expression. By genome-wide analysis, we identified differentially methylated genes and demonstrated that a fraction of these affects ESC differentiation. We found that Dnmt3L exhibits a dual role in DNA methylation because its silencing results in the reduction of the methylation in gene bodies and increased methylation at the transcription start sites of bivalent genes. Specifically, we demonstrate that Dnmt3L-dependent inhibition of DNA methylation is required for ESC differentiation into primordial germ cells (PGCs).
RESULTS

Dnmt3L Is Required for the Differentiation of Mouse ESCs into Primordial Germinal Cells
Dnmt3L is highly expressed in mouse ESCs; its expression decreases after leukemia inhibitory factor (LIF) withdrawal and remains low in embryoid bodies (EBs). In contrast, Dnmt3a and Dnmt3b levels increase following LIF withdrawal, with a peak at day 3 of EB formation, to decrease only at later time points ( Figure 1A ). To understand the role of Dnmt3L in ESCs, we accomplished its acute depletion by RNA interference. Three independent shRNA constructs strongly reduced Dnmt3L expression without altering the expression of Dnmt3a or Dnmt3b in ESCs ( Figure 1B ).
ESCs that were silenced for Dnmt3L showed minor morphological alterations and no variation in the expression of the ESC core factors Oct3/4, Nanog, and Sox2 ( Figure 1C ). In contrast, analysis by quantitative PCR (RT-qPCR) of embryonic markers in Dnmt3L-silenced cells after 7 days of ESC differentiation into EBs showed an unbalanced expression of the markers of the three embryonic germ layers and of the primordial germ cells (PGC) ( Figure 1D ). Importantly, the markers of PGC, Stella (indicated as Dppa3), Acrosin, Haprin, Gcnf, and LH-R were almost undetectable ( Figure 1D ), which suggests that Dnmt3L is involved in PGC establishment.
Next, we analyzed whether Dnmt3L is actually expressed in PGC cells (Stella positive) in EBs at 7 days. Fluorescenceactivated cell sorting (FACS) analysis of EBs showed that Stella-positive PGC cells, which maintain the expression of Oct3/4 (Wei et al., 2008) , were also positive for Dnmt3L ( Figure 1E and Figure S1 ). The coexpression of Stella with Dnmt3L was confirmed by immunofluorescence on ESCs that were differentiated in a monolayer ( Figure S1A ). Dnmt3L mRNA was significantly enriched together with other known markers of PGCs, including Sox2, Acrosin, Haprin, Gcnf, and LH-R, in Stella-positive versus Stella-negative sorted cells from 7-day EBs (Figure 1F) . Moreover, by FACS analysis, we observed a reduction of $85% of the Stella-positive PGCs by Dnmt3L silencing (Figures 1G and H) . To verify that the phenotype observed was not due to silencing-dependent off-target effects, we also performed the knockout of Dnmt3L by targeting the first exon of Dnmt3L using the transcription activator-like effector nucleases (TALENs) (Boch et al., 2009; Moscou and Bogdanove, 2009) . Phenotypic analysis of two independent Dnmt3L knockout ESC clones showed, similarly to the phenotype observed with knockdown experiments, the impairment of PGC markers (compare Figures S1H and S1I with Figures 1D and 1E) .
These experiments establish that Dnmt3L is an early marker of PGCs and that its expression is required for ESC differentiation toward PGCs.
Dnmt3L
Modulates the Expression of the Rhox Genes, which Are Required for ESC-to-PGC Differentiation To identify the genes that are regulated by the Dnmt3L, we performed microarray analysis of the three shRNAs (Pearson correlation R R 0.87, Figure S2A ). The microarray analysis of the control and Dnmt3L knockdown ESCs identified 777 upregulated and 467 downregulated genes (Table S1 ). To identify among the Dnmt3L-regulated genes those that were involved in ESC differentiation into PGCs, we compared this list of Dnmt3L-regulated genes with the genes that are differentially expressed in PGC (Stella-positive) versus non-PGC (Stellanegative) EBs, which were previously published (West et al., 2009 ). This analysis identified 60 genes that are upregulated by Dnmt3L knockdown and that were also upregulated in Stellanegative cells and 67 genes that were downregulated in Dnmt3L knockdown and were also downregulated in Stella-negative cells (Figures 2A and 2B ). Cluster analysis revealed that Dnmt3L was coregulated with three members of the Rhox (reproductive homeobox on X-chromosome) family: Rhox5, Rhox6, and Rhox9 ( Figure 2B ). Further comparison of Dnmt3L-regulated genes versus mouse-derived PGCs and other tissue-regulated genes (Hayashi et al., 2011; Shen et al., 2008; Turbendian et al., 2013) confirmed the coregulation of Dnmt3L with Rhox genes ( Figures S2C and S2D ).
Because Rhox genes encode for transcription factors that are regulated by DNA methylation (Maclean et al., 2011) and their expression is crucial for differentiation of ES cells (MacLean and Wilkinson, 2010) , we further analyzed the expression of the Rhox genes in Dnmt3L knockdown cells. The downregulation of the three Rhox genes upon Dnmt3L silencing was confirmed by RT-qPCR ( Figure 2C ). The specificity of Dnmt3L-dependent regulation was further verified by a complementation assay in which the silencing of the endogenous gene with a siRNA that targets the 3 0 UTR was rescued by the expression of an exogenous Dnmt3L ( Figure 2D ). Furthermore, we observed the downregulation of Rhox genes in Dnmt3L À/À ESCs ( Figure S2E ). Next, we verified whether the knockdown of the Rhox genes could affect the differentiation of ESCs into PGCs. We compared the efficiency of ESC differentiation into PGCs by expressing shRNA for Rhox5, Rhox6, Rhox9, or combinations of these constructs by measuring the number of Stella-positive cells in EBs on day 7. The silencing of Rhox5, either alone or in combination with Rhox6 and/or Rhox9, induced a significant reduction of Stellapositive cells in EBs, whereas the silencing of Rhox6 and Rhox9 did not show a significant reduction in the Stella-positive cells (Figures 2E and S2F) . To establish whether Dnmt3L knockdown prevents PGC formation by repressing Rhox5, we expressed Rhox5 in Dnmt3L-silenced cells ( Figure 2F ). Analysis of Stella-positive cells showed that Rhox5 ectopic expression rescues the block of PGC differentiation following Dnmt3L silencing ( Figure 2G ). Thus, Dnmt3L is required for the differentiation of PGCs via the regulation of Rhox5.
Dnmt3L Maintains Rhox5 Gene Expression by Inhibiting DNA Methylation on the Rhox5 Promoter Region
We next analyzed the pattern of Rhox5 methylation in wild-type and Dnmt3L knockdown ES cells. The Rhox5 gene is transcribed from two alternative promoters: a distal promoter (Pd) and a proximal promoter (Pp) ( Figure 3A ), which transcribe two mRNAs that differ in their 5 0 untranslated regions. In ESCs, only the distal promoter is active (Li et al., 2011) (Figures S2G and S2H) .
Because Dnmt3L has been shown to cooperate with Dntm3a and Dnmt3b to methylate the DNA and because Rhox genes are upregulated in Dntm3a/3b ESC double knockouts (DKOs) (Figure S2G) (Maclean et al., 2011) , we expected that the Dnmt3L knockdown would result in Rhox5 downmethylation. Instead, bisulfite sequencing and methylated DNA immunoprecipitation (MeDIP) of the Rhox5 promoter region revealed that Dnmt3L knockdown induces a significant increase in DNA methylation at both the distal and proximal promoters ( Figures 3A and 3B ). Dnmt3L silencing also affected DNaseI accessibility and increased the level of the repressive mark H3K9me3 within this region (Figures 3C and S2I) . ChIP experiments revealed that Dnmt3L associates with the Rhox5 promoter region, and its signal was significantly reduced by Dnmt3L knockdown ( Figure 3D ). In contrast, Dnmt3a and Dnmt3b showed a low association with the Rhox5 promoter region in wild-type ESCs, and their binding increased significantly upon Dnmt3L knockdown ( Figures 3E and 3F ). To measure the dynamics of Dnmt3L-dependent regulation of Rhox5 we generated Dnmt3L-ER-Dnmt3L À/À stable clones. Time-course analysis of 4-hydroxytamoxifen (OHT) withdrawal, which leads to the cytoplasmic localization of the Dnmt3L-ER fusion protein, showed a concomitant reduction of the Rhox5 expression and an increase of its DNA methylation, together with a reduction of its accessibility ( Figures S2J-S2M ).
The Dual Functions of Dnmt3L in DNA Methylation
The above results demonstrate that Dnmt3L inhibits methylation at the Rhox5 promoter region and suggest that, in this region, Dnmt3L acts as a competitor of Dnmt3a and Dnmt3b. This result is surprising considering that Dnmt3L has been previously reported to cooperate in vitro with Dnmt3a and Dnmt3b to methylate the DNA (Suetake et al., 2004; Chen et al., 2005) . To verify whether the Dnmt3L-dependent inhibition of DNA methylation is a general feature, we performed genome-wide methylation analysis by MeDIP-seq in control and Dnmt3L-silenced cells. The level of 5mC in the control cells along the entire genome, including the gene promoters, and the intragenic and intergenic regions was comparable to other MeDIP-seq analyses (Matarese et al., 2011; Ficz et al., 2011; Pastor et al., 2011) (Figures S3A and S3B) . Dnmt3L silencing resulted in a reduction in the methylation at 14,107 genomic regions ( Figure 4A ). This result is in agreement with the Dnmt3L function of cooperating with Dnmt3a and Dnmt3b to accomplish DNA methylation. However, Dnmt3L silencing also induced a significant increase in methylation in 5,724 genomic regions ( Figure 4A ), which suggests that Dnmt3L also plays a role in limiting the DNA methylation. The reduction in methylation occurred mainly within the gene bodies, whereas the increase in methylation was more centered at the transcription start site (TSS) ( Figure 4B ). Analysis of the methylation distribution was performed by using a list of the genes that was ordered with respect to the level of their See also Figure S2 and Tables S1 and S2. expression; this analysis showed a significant increase in methylation at the promoters of genes that were not expressed or were expressed at a low level ( Figures 4C and S3C ). Gene ontology analysis showed that the genes that had increased methylation were significantly enriched for developmental genes, most of which are bivalent in ESCs ( Figures S3D and  S3E ). The reduction in methylation was centered more on the body of genes that had higher expression levels and included genes that are involved in cell growth and metabolism ( Figures  4C and S3E) .
To explore the relation between histone modifications and the Dnmt3L-dependent DNA methylation, we compared the increase in DNA methylation that resulted from Dnmt3L silencing with respect to histone modifications. Dnmt3L-dependent methylation ( Figure 4D , loss of 5mC) showed a 9% overlap with the bodies of the H3K4me3 genes over a total of 7,931 (p < 10 -7 ), which is in agreement with a role for Dnmt3L in cooperating with Dnmt3a and Dnmt3b to methylate DNA. Importantly, we also found that the increase in DNA methylation correlates with bivalent genes because 55% of the H3K27me3/ H3K4me3-positive genes over a total of 2,189 genes (p = 0.00) showed an increase in DNA methylation following Dnmt3L silencing ( Figure 4D , gain of 5mC). Remarkably, Dnmt3L silencing induced an increase of 5mC in the H3K27me3-positive regions (Figure 4E) . Interestingly, the analysis of the gain of methylation on the H3K27me3 promoters classified by the level of DNA methylation resulted to be independent of their initial methylation state and correlates with the increase of DNA methylation that is observed during ESC differentiation (Stadler et al., 2011) (Figures S3F and S3G) . The gain in 5mC was validated by the bisulfite technique (Figure S4) . These results establish that one role of Dnmt3L in ESCs is to maintain the hypomethylated state of the bivalent genes.
Dnmt3L Forms a Complex with PRC2 via Its Direct Interaction with Ezh2
The above results show that, in ESCs, the increase in DNA methylation by Dnmt3L silencing overlaps with H3K27me3 modification. In differentiated cells, the Polycomb PRC2 complex associates with Dnmt3a and Dnmt3b (Viré et al., 2006) . However, in ESCs, the majority of H3K27me3 genes are hypomethylated (Fouse et al., 2008; Rush et al., 2009) , which suggests that a more complex interplay between PRC2 and DNA methyltransferases takes place in ESCs.
By using coimmunoprecipitation of endogenous proteins, we tested whether the PRC2 complex could interact with Dnmt3L.
We observed that, in ESCs, in addition to Dnmt3a and Dnmt3b, Dntm3L also coimmunoprecipitated with Ezh2 and Suz12 (Figure 5A) , and in the reciprocal experiment, both proteins of the PRC2 complex coimmunoprecipitated with Dnmt3L ( Figure S5A ). We further demonstrated through an in vitro interaction assay using the recombinant FLAG-Dnmt3L and GST-Ezh2 proteins that the observed interaction is direct ( Figures 5B and S5B) . Moreover, by increasing salt concentrations, we observed a higher affinity of Ezh2 with Dnmt3L with respect to Dnmt3a/b ( Figures S5B and S5C) . By deletion mutants, we mapped the interaction of Dnmt3L with Ezh2 to the Dnmt3L N-terminal part, within its PHD like domain; in agreement with previous reports (Suetake et al., 2004) , the deletion of the C-terminal domain abolished its interaction with Dnmt3a ( Figure 5C ). Furthermore, we fractionated the nuclear protein complexes through gel filtration chromatography and immunoprecipitated each fraction with anti-Dnmt3L antibody. Western blot analysis revealed that the Dnmt3L protein immunoprecipitated different complexes containing Ezh2, Dnmt3a, or Dnmt3b at different molecular weights ( Figure 5D ).
Dnmt3L Competes with Dnmt3a and Dnmt3b for Binding with PRC2
The above results suggest that Dnmt3L forms a complex with PRC2 that is independent from Dnmt3a or Dnmt3b. To verify this hypothesis, we first coimmunoprecipitated Dnmt3L with Ezh2 in Dnmt3a/3b DKO ESCs and still observed the reciprocal interaction ( Figure 6A ). Then, we immunodepleted both Dnmt3a and Dnmt3b from the nuclear extracts of wild-type ESCs to remove all Dnmt3a-and Dnmt3b-associated complexes. The immunodepleted extracts still coimmunoprecipitated Dnmt3L with Ezh2 but no longer coimmunoprecipitated Dnmt3a or Dnmt3b with Ezh2 ( Figure S6A ). Finally, we performed a double immunoprecipitation of transfected FLAG-Dnmt3L. The first immunoprecipitation performed with the anti-FLAG antibody coimmunoprecipitated Ezh2 as well as the Dnmt3a and Dnmt3b proteins ( Figure 6B, lane 1) . Then, we performed re-immunoprecipitations using antibodies against the endogenous proteins of interest. We observed that Dnmt3L forms a different complex with Ezh2 compared with the complex that it forms with Dnmt3a/3b ( Figure 6B, lanes 3-5) . Taken together, the above experiments establish that, in ESCs, Dnmt3L interacts directly with PRC2 in a complex that is independent from those formed by PRC2 with Dnmt3a or Dnmt3b.
Because the ChIP experiments showed increased binding of Dnmt3a and Dnmt3b on the Rhox5 gene in Dnmt3L-silenced cells ( Figures 3E and 3F) , we further verified whether Dnmt3L could compete with Dnmt3a or Dnmt3b for the interaction with the PRC2 complex. We observed that there was an increase of the Ezh2 coimmunoprecipitate with Dnmt3a and Dnmt3b in extracts from Dnmt3L-silenced cells, compared with the extracts from control cells ( Figure 6C , top) as well as a significant increase of the DNA methylation activity of the immunoprecipitated fractions (Figures 6C, bottom and S6B ). To further demonstrate the competition between Dnmt3L and Dnmt3a/3b for the interaction with the PRC2 complex, we analyzed the immunoprecipitate of Ezh2 with Dnmt3 proteins in HEK293 cells, which do not express Dnmt3L, by expressing in these cells a FLAG-tagged Dnmt3L under an inducible promoter. Increasing the concentration of FLAGDnmt3L completely abolished the coimmunoprecipitation of Ezh2 with Dnmt3a and Dnmt3b ( Figure 6D ). These experiments demonstrate that Dnmt3L is a direct competitor of Dnmt3a and Dnmt3b for the interaction with PRC2.
Dnmt3L Is Recruited by PRC2 at H3K27me3 Genes
Because Rhox5 is a bivalent gene that is marked by H3K27me3 and is bound by Ezh2 ( Figure S7A ) (Li et al., 2011) , we further analyzed the interplay between Dnmt3L and PRC2 on its promoter region ( Figure 7A ). Suz12 silencing resulted in a significant reduction of PRC2 binding to the Rhox5 promoter region, as measured by the chromatin immunoprecipitation (ChIP) of Ezh2 ( Figures 7B  and 7C ), together with a reduction in H3K27me3 ( Figure S7B) . Importantly, the reduction of PRC2 association with Rhox5 significantly affected the Dnmt3L binding to this region ( Figure 7D ), which demonstrates that Dnmt3L is recruited by PRC2 on Rhox5.
To verify whether Dnmt3L is recruited to the chromatin via PRC2 genome wide, we performed ChIP-seq analysis of BioDnmt3L in control or Suz12-silenced ESCs ( Figure 7E ). As expected, we observed that Bio-Dnmt3L was localized on gene bodies of transcriptionally active genes involved in cell metabolism and on the H3K27me3-positive promoters of developmental genes ( Figures 7F-7I and S7C-S7E) . Analysis of BioDnmt3L distribution on genes ordered by the level of H3K27me3 showed a significant reduction of Bio-Dnmt3L binding specifically at the H3K27me3 promoters, but not on the H3K27me3-negative genes ( Figures 7J and 7K) , as is evident from the representative cluster of the Hoxa genes ( Figure 7L ). In contrast, the silencing of Dnmt3L did not alter the genomic distribution of PRC2 measured by ChIP-seq of Suz12 ( Figure S7F-S7I ).
DISCUSSION
Although it has been demonstrated that there is a correlation between certain epigenetic marks and DNA methylation (Meissner (A) Dnmt3L coimmunoprecipitates with Ezh2 protein also in Dnmt3a/b DKO ESCs. The endogenous proteins were immunoprecipitated using the indicated antibodies. One percent of the nuclear extract was loaded as an input. (B) Re-immunoprecipitation analysis demonstrates that Dnmt3L together with Ezh2 occur in a protein complex that does not contain Dnmt3a/3b proteins. The ESCs were transiently transfected with FLAG-Dnmt3L, and the first immunoprecipitation was performed using the anti-FLAG antibody. The interacting proteins were eluted with FLAG peptide and were subsequently re-immunoprecipitated using the indicated antibodies. (C) Dnmt3L knockdown in ESCs leads to an increase in the interaction between the Ezh2 and Dnmt3a/3b proteins and, in addition, leads to a corresponding increase in the DNA methylation activity of the immunoprecipitates (bottom). The immunoprecipitation experiments were performed using two different shRNAs for Dnmt3L. *p < 0.001. Data are represented as mean ± SD. (D) Competition analysis in HEK293 cells that stably express the FLAG-Dnmt3L protein. The induction of FLAG-Dnmt3L protein by the tetracycline treatment for the indicated times leads to a loss in the interaction between the Ezh2 and Dnmt3a/3b proteins, as shown by immunoprecipitation. See also Figure S6 . et al., 2008) , the mechanism that regulates its specificity has not yet been clarified. Here, we have shown that, in ESCs, the noncatalytic member of the de novo DNA methyltransferases Dnmt3L plays a regulatory role on the DNA methylation by enhancing or inhibiting the activity of Dnmt3a and Dnmt3b in different chromatin contexts. Specifically, Dnmt3L enhances the DNA methylation at gene bodies of active genes and prevents DNA methylation at the promoters of H3K27me3-positive genes.
We observed that, in ESCs, Dnmt3L interacts with Dnmt3a and Dnmt3b, suggesting that Dnmt3L could stimulate their activity and/or their redistribution. This result is in agreement with the previous observation that Dnmt3L enhances in vitro the methylation activity of Dnmt3a and Dnmt3b (Suetake et al., 2004) and mediates the release of Dnmt3a from heterochromatic to euchromatic regions (Jurkowska et al., 2011a) .
In ESCs, the repression of developmental genes is mediated by the Polycomb complex, which provides a reversible repression that ensures their dynamic regulation either by gene activation or by DNA methylation during differentiation Lee et al., 2006; Mohn et al., 2008; Schuettengruber and Cavalli, 2009) .
Our genome-wide analysis shows that Dnmt3L, recruited by PRC2 on the H3K27me3 promoters, inhibits the methylation of the DNA at such promoters, suggesting that Dnmt3L cooperates with Polycomb to keep developmental genes able to be activated upon differentiation.
It was previously shown that PRC2 is not required for ESC selfrenewal but that ESCs that are defective in their PRC2 function show misregulation in their developmental programs (Pasini et al., 2007; Margueron and Reinberg, 2011) . Similarly, Dnmt3L-dependent modulation of DNA methylation is not required for ESC maintenance, but it is necessary for the correct differentiation of ESCs. Previous studies have established that Dnmt3L is required in germ cells for the methylation of DNA of imprinted genes (Hata et al., 2002; Kaneda et al., 2004; Bourc'his et al., 2001) . We have now observed that Dnmt3L also plays a role in ESC commitment because Dnmt3L knockdown showed unbalanced differentiation and failure to form PGCs. We found that the expression of the homeotic gene Rhox5 depends on Dnmt3L in ESCs, and we demonstrated that Rhox5 expression is required for ESC differentiation into PGCs. In the absence of Dnmt3L, Dnmt3a and Dnmt3b significantly increase their association to the Rhox5 promoter region, which becomes heavily DNA methylated, leading to gene repression. PRC2 is the key player of this regulation because we demonstrated that Dnmt3L interacts directly with Ezh2 of the PRC2 complex and that Dnmt3L is recruited to the Rhox5 promoter region via PRC2 through its PHD-like domain in competition with Dnmt3a and Dnmt3b. Thus, on the Rhox5 promoter region, Dnmt3L binding via PRC2 inhibits the recruitment of Dnmt3a and Dnmt3b, which keeps the region hypomethylated.
Interestingly, the PHD-like domain is conserved in all three Dnmts, and it has been previously demonstrated to be instrumental for the recruitment of these methylases to the unmethylated H3K4 Ooi et al., 2007) , which is not present on promoters of active and bivalent genes. We have now described a new regulatory function of the PHD-like domain that mediates the competition of Dnmt3L with Dnmt3a and Dnmt3b. We propose a model in which Dnmt3L, recruited to the chromatin at the Polycomb target genes, inhibits the recruitment of the active DNA methyltransferases Dnmt3a and Dnmt3b, in this way inhibiting the methylation at the H3K27me3-positive regions. Upon ESC differentiation, the downregulation of Dnmt3L permits de novo DNA methylation on the sites that maintain H3K27me3 modification and transcriptional activation of the genes that lose this chromatin mark.
EXPERIMENTAL PROCEDURES Cell Culture and Differentiation Conditions
Mouse ESCs were cultured in DMEM high-glucose medium (Invitrogen) supplemented with 15% FBS (Millipore), 0.1 mM nonessential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 0.1 mM 2-mercaptoethanol, 1,500 U/ml LIF (Millipore), 25 U of penicillin/ml, and 25 mg of streptomycin/ml.
Culture and differentiation of E14 mouse ESCs into EBs has been described previously (Neri et al., 2012) . For monolayer differentiation, 3 3 10 5 cells per well were plated on collagen IV (Col. IV)-coated 6-well dishes (Becton Dickinson) in differentiation medium (a-MEM with 15% FCS and 50mM 2-mercaptoethanol). The T-Rex 293 cell line was cultured in DMEM high-glucose medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Sigma), 1 mM sodium pyruvate (Invitrogen), 50 U of penicillin/ml, and 50 mg of streptomycin/ml.
Generation of Dnmt3L
À/À ESCs Knockout was performed using TALEN technology. In brief, cells were transfected with the two TALEN constructs targeting Exon 1 of murine Dnmt3L and after 16 hr were seeded as a single cell. After 1 week, clones were picked and screened by western blotting. Positive clones were analyzed by genomic sequencing of the TALEN target. For generation of a Dnmt3L-ER-Dnmt3L À/À stable ES clone, Dnmt3L KO cells were transduced with pBABE-Dnmt3L-ER retrovirus and were maintained under the selection with 1 mg/ml of puromycin for 7 days. Cells were treated with 1 mM of 4-OHT to induce nuclear localization of Dnmt3L-ER.
Generation of Mouse BirA-ES Cell Lines Stably Expressing BioDnmt3L
To obtain Bio-Dnmt3L stable clone, BirA-ESCs (Driegen et al., 2005) were transfected with linearized Bio-Dnmt3L construct using Lipofectamine 2000 Transfection Reagent (Invitrogen) according to the manufacturer's protocol. Transfected cells were cultured for 10 days in growth medium with Blasticidin (Sigma), and drug-resistant clones were selected for Dnmt3L expression. See also Figure S7 .
Nuclear Protein Extractions
Cells were harvested in PBS 13 and were resuspended in Isotonic Buffer (20mM HEPES [pH 7.5], 100 mM NaCl, 250 mM sucrose, 5 mM MgCl 2 , and 5 mM ZnCl 2 ). Successively, cells were resuspended in isotonic buffer supplemented with 1% NP-40 to isolate the nuclei. The isolated nuclei were resuspended in digestion buffer (50 mM Tris-HCl [pH 8.0], 100 mM NaCl, 250 mM sucrose, 0.5 mM MgCl 2 , 5 mM CaCl 2 , and 5 mM ZnCl 2 ) and were treated with Microccocal Nuclease at 30 C for 10 min.
Immunoprecipitation
Nuclear proteins from about 10 3 10 6 cells were incubated with 3 mg of specific antibody overnight at 4 C. Immunocomplexes were incubated with protein-Gconjugated magnetic beads (DYNAL, Invitrogen) for 2 hr at 4 C. Samples were washed four times with digestion buffer supplemented with 0.1% NP-40 at RT. Proteins were eluted by incubating with 0.4M NaCl TE buffer for 30 min and were analyzed by western blotting.
In Vitro Interaction Assay
The in vitro interaction assay was performed as previously described (Galvagni et al., 2001 ) (see Extended Experimental Procedures for details).
Microarray Analysis
Microarray analysis was performed on the Illumina Platform, and the results were analyzed using the BeadStudio Gene Expression Module (GX) (see Extended Experimental Procedures for details).
MeDIP-Seq and ChIP-Seq Analysis
MeDIP was performed using the MeDIP kit (55009, Active Motif), according to the manufacturer's protocol. The ChIP of Ezh2 was performed as previously described using 1% SDS buffer (Mikkelsen et al., 2007) . ChIP of Bio-Dnmt3L and bioinformatics analyses are described in Extended Experimental Procedures.
Bisulfite Analysis
Bisulfite conversion was performed using EpiTect Bisulfite Kits (QIAGEN), and converted DNA was amplified using AccuPrime Taq DNA Polymerase (Invitrogen). The PCR product was cloned in TOPO-Blunt (using Zero Blunt TOPO PCR Cloning Kit, Invitrogen), and colonies were sequenced. Oligos for amplification were designed using Meth Primer Software (http://www.urogene.org/cgi-bin/ methprimer/methprimer.cgi). Oligonucleotide sequences are in Table S5 .
Chromatin Accessibility Assay
Chromatin accessibility was performed using EpiQ Chromatin Analysis Kit (from Biorad), according to the manufacturer's protocol. DNA was analyzed by quantitative real-time PCR by using a SYBR GreenER kit (Invitrogen).
Antibodies
The antibodies were purchased by Abcam (anti-Dnmt3l ab3493; anti-Dnmt3a; anti-Dnmt3b; anti-Nanog; anti-H3K9me3), by Immgenex (anti-Dnmt3a; antiDnmt3b; anti-Dnmt1, anti-Rhox5), by Cell Signaling (anti-Ezh2; anti-Suz12; anti-Rbbp4/7), by Millipore (anti-Sox2; anti-H3K27me3), by Sigma (anti-FLAG M2), by SantaCruz (anti-Oct3/4 sc-5279, anti-LaminA sc-20680), and by Neuromics (anti-Stella GT15240). Antibody anti-Dnmt3L was kindly provided by Dr. S. Yamanaka (Kyoto University, Japan).
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The ChIP-seq, MeDIP-seq, and expression microarray data sets have been deposited in Gene Expression Omnibus (GEO) under the accession number GSE44644. 
SUPPLEMENTAL INFORMATION
